Dapsone (Jacobus Pharmaceutical Company, Inc.)
Welcome to the PulseAid listing for the Dapsone drug offered from Jacobus Pharmaceutical Company, Inc.. This Sulfone [EPC],Sulfones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Jacobus Pharmaceutical Company, Inc. |
NON-PROPRIETARY NAME: | Dapsone |
SUBSTANCE NAME: | DAPSONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Sulfone [EPC],Sulfones [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1979-07-03 |
END MARKETING DATE: | 0000-00-00 |
Dapsone HUMAN PRESCRIPTION DRUG Details:
Item Description | Dapsone from Jacobus Pharmaceutical Company, Inc. |
LABELER NAME: | Jacobus Pharmaceutical Company, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 1979-07-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49938-101_3bf19f3f-9f43-4f24-85de-8d5ba53355ae |
PRODUCT NDC: | 49938-101 |
APPLICATION NUMBER: | ANDA086842 |
Other DAPSONE Pharmaceutical Manufacturers / Labelers: